Neuland Laboratories Announces 42nd Annual General Meeting and Integrated Annual Report for FY 2025-26
Neuland Laboratories Limited has scheduled the company's 42nd Annual General Meeting (AGM) to transact business related to its operations and provide stakeholders with the Integrated Annual Report for the financial year 2025-26.The AGM is set to be held on Tuesday, August 4, 2026, at 10:00 a.m. (IST). The meeting will be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), allowing participation without the physical presence of shareholders at a common venue.
The company has made available the Notice of the AGM and the Integrated Annual Report for FY 2025-26 to all shareholders. While electronic copies are being sent to shareholders whose email addresses are registered with the Company or Depository Participant(s) (DP), an alternative access method is provided for those without registration.
Shareholders who do not have their email address registered with the company or its Registrar and Share Transfer Agent (RTA) are advised that they cannot receive the Notice of the AGM and Integrated Annual Report electronically. For these shareholders, the materials can be accessed through a specific weblink or QR code provided by Neuland Laboratories Limited.
The Notice of the AGM and Integrated Annual Report for the financial year 2025-26 is also available on the company's official website and on the websites of listed stock exchanges and National Securities Depository Limited (NSDL). Shareholders wishing to register their email address should approach their respective DP, or write to the RTA if holding shares in physical form. Those requiring a physical copy of the Integrated Annual Report for FY 2025-26 are requested to send a request via email.
NEULANDLAB Stock Price Movement
Today, Neuland Laboratories Limited shares edged higher to close at ₹19542 after gaining 3.76%, marking robust movement in the pharmaceutical stocks. The company’s equity traded 97,154 shares today, closing within striking distance of its 52-week high of ₹20089.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.